Species:


How do you choose the right reproductive vaccine?

Reproductive diseases can lead to significant losses.

Important
reproductive diseases

Potential
herd impacts

Bovine Viral Diarrhea (BVD)

  • Can lead to embryonic loss and abortion
  • Persistently infected (PI) calves can shed the virus and continue to infect the herd
  • Can result in birth defects

Infectious Bovine Rhinotracheitis (IBR)

  • Can result in infertility problems and abortion

Why use reproductive vaccines?

  • The fetus is without protection for most of the pregnancy, relying on the dam’s immune system
  • Disease protection is crucial until the fetus develops its own immune system in the third trimester
  • Vaccination programs can help improve colostrum quality, to help calves fight off early infection

Vaccination helps protect reproductive health.

Factors to consider when selecting a vaccine:

  • Is it a modified-live virus (MLV) or killed vaccine? MLV vaccines help provide a more rapid, longer-lasting and clinically effective immune responses than killed vaccines.1-6
  • Safety. Not all vaccines are licensed for use in pregnant cows and calves nursing pregnant cows.
  • Duration of immunity. Are cattle protected during critical exposure periods?
  • Does it offer a fetal protection guarantee? Does it assure protection against IBR abortion and BVD persistently infected calves?

The most comprehensive Fetal Protection guarantee.

Zoetis stands behind the leading7 BOVI-SHIELD GOLD® HB, BOVISHIELD GOLD FP®, CATTLEMASTER GOLD FP® AND PREGGUARD® GOLD FP® product lines with the Fetal Protection Guarantee. When these products are used according to label directions, Zoetis guarantees:

  • No calves will be born persistently infected with BVD
  • Cows are protected against IBR abortions

Want to learn more?

Helping protect fetal health and understanding reproductive vaccines PDF

Fetal Protection Guarantee PDF

Fetal protection indications give Bovi-Shield GOLD®FP®, CattleMaster®GOLD FP®, and PregGuard® GOLD FP® important advantages PDF

Fetal protection indications give Bovi-Shield GOLD®FP®, CattleMaster®GOLD FP®, and PregGuard® GOLD FP® important advantages PDF

Rising calf prices warrant attention to fetal protection PDF

Study reveals cattle producers’ most important vaccine concerns PDF

Work with your veterinarian to develop a reproductive
vaccination program that’s tailored to your operation.

The Zoetis 100% BVD PI-Free Guarantee and the IBR Abortion Guarantee will be administered through Zoetis VMIPS (Veterinary Medical Information and Product Support) at 800-366-5288. Proof of purchase is required. Calves born to BVD PI-positive cows or heifers do not qualify for the guarantee. This guarantee does not apply to, and Zoetis shall not be liable for, any (x) damages caused as a result of the improper handling, misuse or abuse of the vaccines that are the subject of this guarantee, or the willful misconduct or negligence of any third party, or (y) any indirect, punitive, special, incidental or consequential damages. Zoetis reserves the right to modify or cancel the terms and conditions of this guarantee.

1 Cortese VS. Bovine virus diarrhea virus and mucosal disease. In: Howard JL, Smith RA, eds. Current Veterinary Therapy 4, Food Animal Practice. Philadelphia, PA: WB Saunders; 1999;286-291.
2 Daly R. Timing of vaccination in beef cattle herds, in Proceedings. Applied Reproductive Strategies in Beef Cattle, Rapid City, SD. 2006:190-195.
3 Jones C, Chowdhury S. A review of the biology of bovine herpesvirus type 1 (BHV-1), and its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim Health Res Rev 2007;8:187-205.
4 Osorio FA. Infectious bovine rhinotracheitis and other clinical syndromes caused by bovine herpesvirus types 1 and 5. In: Howard JL, Smith RA, eds. Current Veterinary Therapy 4, Food Animal Practice. Philadelphia, PA: W.B. Saunders; 1999:283-286.
5 Rodning SP, Marley MSD, Zhang Y, et al. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus. Theriogenology 2010;73:1154-1163.
6 van Drunen Little-van den Hurk S. Cell-mediated immune responses induced by BHV-1: rational vaccine design. Expert Rev Vaccines 2007;6:369-380.
7 Animalytix U.S. market report series. June 2013-May 2014.